Board of Directors
The Board of Directors oversees the day-to-day running of our association and the Chair is the highest representative of AseBio. The assembly held in December 2021 chose the candidacy with Ana Polanco (Merck) as chairwoman and Belén Barreiro (Ingenasa), Elena Rivas (A4Cell) y Javier Terriente (Zeclinics) as the three vice-presidents. They will hold these offices until late 2023.

CEO at Arrays for Cell Nanodevices, SL

General Director at 3P Biopharmaceuticals since 2007, Dámaso Molero has extensive experience in pharmaceutical production, with 10 years as plant director at Shionogi.

CEO and Vice-president of Business Development and Licensing at AbilityPharma since 2009. In parallel, he works as a consultant for biotech projects at investment firm Kieretsu Forum Spain.

President and CEO of AlgaEnergy, a company working to create products from microalgae. He leads R&D projects in microalgae biotechnology.

Executive Chairman of the Board at AtrysHealth. Torres, a physician specialising in Clinical Pharmacology, is also on the board of various social organisations.

Director of Agricultural Policies and Institutional Relations at Bayer Crop Science Iberia, the agro division of the multinational, which is the third largest company in the world in products for agriculture.

CEO at Science & Innovation Link Office (SILO)